We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The South Korean drugmaker is testing the drug in partnership with Mankind Pharma which will continue the second and third phases of trials in India on mild and severe coronavirus patients.